392 related articles for article (PubMed ID: 17333224)
1. Antifungal susceptibility testing of Trichophyton rubrum by E-test.
da Silva Barros ME; de Assis Santos D; Soares Hamdan J
Arch Dermatol Res; 2007 May; 299(2):107-9. PubMed ID: 17333224
[TBL] [Abstract][Full Text] [Related]
2. Widespread, chronic, and fluconazole-resistant Trichophyton rubrum infection in an immunocompetent patient.
Balci DD; Cetin M
Mycoses; 2008 Nov; 51(6):546-8. PubMed ID: 18422918
[TBL] [Abstract][Full Text] [Related]
3. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole.
Santos DA; Hamdan JS
Mycoses; 2007 Jul; 50(4):286-9. PubMed ID: 17576321
[TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
Sarifakioglu E; Seçkin D; Demirbilek M; Can F
Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
[TBL] [Abstract][Full Text] [Related]
6. In vitro methods for antifungal susceptibility testing of Trichophyton spp.
Barros ME; Santos Dde A; Hamdan JS
Mycol Res; 2006 Nov; 110(Pt 11):1355-60. PubMed ID: 17070026
[TBL] [Abstract][Full Text] [Related]
7. Antifungal activities of azole agents against the Malassezia species.
Miranda KC; de Araujo CR; Costa CR; Passos XS; de Fátima Lisboa Fernandes O; do Rosário Rodrigues Silva M
Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
[TBL] [Abstract][Full Text] [Related]
8. Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994-1996 and 1997-2005.
Aller AI; Claro R; Castro C; Serrano C; Colom MF; Martín-Mazuelos E
Chemotherapy; 2007; 53(4):300-5. PubMed ID: 17496416
[TBL] [Abstract][Full Text] [Related]
9. Comparison of a glucose consumption based method with the CLSI M38-A method for testing antifungal susceptibility of Trichophyton rubrum and Trichophyton mentagrophytes.
Zhang J; Chen J; Huang HQ; Xi LY; Lai W; Xue RZ; Zhang XH; Chen RZ
Chin Med J (Engl); 2010 Jul; 123(14):1909-14. PubMed ID: 20819577
[TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibility and genetic similarity of sequential isolates of Trichophyton rubrum from an immunocompetent patient with chronic dermatophytosis.
Cordeiro RA; Brilhante RS; Rocha MF; Rabenhorsch SH; Moreira JL; Grangeiro TB; Sidrim JJ
Clin Exp Dermatol; 2006 Jan; 31(1):122-4. PubMed ID: 16309501
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
12. Molecular typing and antifungal susceptibility of Trichophyton rubrum isolates from patients with onychomycosis pre- and post-treatment.
de Assis Santos D; de Carvalho Araújo RA; Kohler LM; Machado-Pinto J; Hamdan JS; Cisalpino PS
Int J Antimicrob Agents; 2007 May; 29(5):563-9. PubMed ID: 17331707
[TBL] [Abstract][Full Text] [Related]
13. Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing.
Buchta V; Vejsova M; Vale-Silva LA
Folia Microbiol (Praha); 2008; 53(2):153-60. PubMed ID: 18837162
[TBL] [Abstract][Full Text] [Related]
14. Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ;
Diagn Microbiol Infect Dis; 2009 Sep; 65(1):27-34. PubMed ID: 19679232
[TBL] [Abstract][Full Text] [Related]
15.
Singh SK; Patwa DK; Tilak R; Das A; Singh TB
Indian J Dermatol Venereol Leprol; 2019; 85(4):388-392. PubMed ID: 30950409
[TBL] [Abstract][Full Text] [Related]
16. Broth medium for microdilution susceptibility tests of fluconazole and voriconazole.
Barry A; Brown S; Traczewski M
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):407-10. PubMed ID: 12072930
[No Abstract] [Full Text] [Related]
17. Investigation of the antifungal potential of linalool against clinical isolates of fluconazole resistant Trichophyton rubrum.
de Oliveira Lima MI; Araújo de Medeiros AC; Souza Silva KV; Cardoso GN; de Oliveira Lima E; de Oliveira Pereira F
J Mycol Med; 2017 Jun; 27(2):195-202. PubMed ID: 28189377
[TBL] [Abstract][Full Text] [Related]
18. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
Lee SC; Lo HJ; Fung CP; Lee N; See LC
J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647
[TBL] [Abstract][Full Text] [Related]
19. [Resistance to azolic compounds in clinical Trichophyton spp. strains].
Méndez-Tovar LJ; Manzano-Gayosso P; Velásquez-Hernández V; Millan-Chiu B; Hernández-Hernández F; Mondragón-González R; López-Martínez R
Rev Iberoam Micol; 2007 Dec; 24(4):320-2. PubMed ID: 18095769
[TBL] [Abstract][Full Text] [Related]
20. Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
Koc AN; Silici S; Ayangil D; Ferahbaş A; Cankaya S
Mycoses; 2005 May; 48(3):205-10. PubMed ID: 15842339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
